Drugs Xagena News

Vargatef for locally advanced, metastatic or locally recurrent non-small cell lung cancer patients with advanced adenocarcinoma after first-line chemotherapy, approved in the European Union

The European Commission has granted EU marketing authorisation for Vargatef ( Nintedanib ). Vargatef in combination with Docetaxel ( Taxotere ) is indicated for use in adult patients with locally adva ...

Updated international treatment guidelines for idiopathic pulmonary fibrosis: Ofev improves disease progression as measured by rate of forced vital capacity decline and mortality

2015 ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Guideline suggests that clinicians use Ofev ( Nintedanib ) in patients with idiopa ...

FDA has approved Ofev, first treatment for patients with interstitial lung disease associated with systemic sclerosis or scleroderma

The FDA ( U.S. Food and Drug Administration ) has approved Ofev ( Nintedanib ) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with syste ...

DrugsNews.net

Search results for "Nintedanib"

Vargatef for locally advanced, metastatic or locally recurrent non-small cell lung cancer patients with advanced adenocarcinoma after first-line chemotherapy, approved in the European Union

Updated international treatment guidelines for idiopathic pulmonary fibrosis: Ofev improves disease progression as measured by rate of forced vital capacity decline and mortality

FDA has approved Ofev, first treatment for patients with interstitial lung disease associated with systemic sclerosis or scleroderma

MedTV